|
|
||||||||
in rat liver
Department of Physiology, Göteborg University, S-405 30 Goteborg, Sweden
The aim of this study was to
investigate the interaction between long-chain fatty acids (LCFA) and
growth hormone (GH) in the regulation of liver fatty acid binding
protein (LFABP) and peroxisome proliferator-activated receptor-
(PPAR
). Cultured rat hepatocytes were given oleic acid (OA; 500 µM) and GH (100 ng/ml) for 3 days. LFABP mRNA increased 3.6-fold by
GH and 5.7-fold by OA, and combined incubation with GH and OA increased
LFABP mRNA 17.6-fold. PPAR
mRNA was decreased 50% by GH, but OA had no effect. Hypophysectomized (Hx) female rats were treated with L-thyroxine, cortisol, GH, and dietary fat for 7 days.
PPAR
mRNA levels were three- to fourfold higher in Hx than in normal
female rats. GH decreased PPAR
mRNA 50% in Hx rats. Dietary
triglycerides (10% corn oil) increased LFABP mRNA and cytosolic LFABP
about twofold but had no effect on PPAR
mRNA in Hx rats. GH and
dietary triglycerides had an additive effect on LFABP expression.
Dietary triglycerides increased mitochondrial hydroxymethylglutaryl-CoA synthase mRNA only in the presence of GH. The diet increased serum triglycerides in Hx rats, and GH treatment prevented this increase. Addition of cholesterol to the diet did not influence LFABP levels but
mitigated increased hepatic triglyceride content. In summary, these
studies show that GH regulates LFABP expression independently of
PPAR
. Moreover, GH has different effects on PPAR
-responsive genes
and does not counteract the effect of LCFA on the expression of these
gene products.
peroxisome proliferator-activated receptor-
; hepatocytes; mitochondrial hydroxymethylglutaryl coenzyme A synthase; dietary fat; cholesterol; hypophysectomy; serum triglycerides; oleic acid
This article has been cited by other articles:
![]() |
N. Anderson and J. Borlak Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Trepp, M. Fluck, C. Stettler, C. Boesch, M. Ith, R. Kreis, H. Hoppeler, H. Howald, J.-P. Schmid, P. Diem, et al. Effect of GH on human skeletal muscle lipid metabolism in GH deficiency Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1127 - E1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Olsson, M. Bohlooly-Y, O. Brusehed, O. G. P. Isaksson, B. Ahren, S.-O. Olofsson, J. Oscarsson, and J. Tornell Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E504 - E511. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Linden, K. Lindberg, J. Oscarsson, C. Claesson, L. Asp, L. Li, M. Gustafsson, J. Boren, and S.-O. Olofsson Influence of Peroxisome Proliferator-activated Receptor alpha Agonists on the Intracellular Turnover and Secretion of Apolipoprotein (Apo) B-100 and ApoB-48 J. Biol. Chem., June 14, 2002; 277(25): 23044 - 23053. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |